Longitudinal PSA changes in men with and without prostate cancer: Assessment of prostate cancer risk
- 14 February 2005
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 64 (3) , 240-245
- https://doi.org/10.1002/pros.20210
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Biopsy indication—a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c diseaseUrology, 2004
- Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM)Urology, 2004
- Early detection of prostate cancer with low PSA cut‐off values leads to significant stage migration in radical prostatectomy specimensThe Prostate, 2003
- Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trialInternational Journal of Cancer, 2001
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998
- Prostate carcinoma screening in the county of Tyrol, AustriaCancer, 1997
- Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigenUrology, 1996
- Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic CurvesJournal of Urology, 1994
- Serum Prostate-Specific Antigen in a Community-Based Population of Healthy MenJAMA, 1993
- Serum Prostate Specific Antigen as Pre-Screening Test for Prostate CancerJournal of Urology, 1992